Investigating the additive interaction of QT-prolonging drugs in older people using claims data
IntroductionDrugs that potentially prolong the QT interval carry the risk of life-threatening Torsades de pointes (TdP) ventricular arrhythmia.ObjectiveThe objective of this study was to investigate the potential additive risk for ventricular arrhythmia with concomitant prescriptions of QT-prolongin...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Drug safety
Year: 2017, Jahrgang: 40, Heft: 2, Pages: 133-144 |
| ISSN: | 1179-1942 |
| DOI: | 10.1007/s40264-016-0477-y |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s40264-016-0477-y Verlag, Volltext: https://link.springer.com/content/pdf/10.1007%2Fs40264-016-0477-y.pdf 
|
| Verfasserangaben: | Andreas D. Meid, Anna von Medem, Dirk Heider, Jürgen-Bernhard Adler, Christian Günster, Hanna M. Seidling, Renate Quinzler, Hans-Helmut König, Walter E. Haefeli |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1581230028 | ||
| 003 | DE-627 | ||
| 005 | 20220815015439.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180924s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40264-016-0477-y |2 doi | |
| 035 | |a (DE-627)1581230028 | ||
| 035 | |a (DE-576)511230028 | ||
| 035 | |a (DE-599)BSZ511230028 | ||
| 035 | |a (OCoLC)1341018723 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Meid, Andreas |d 1981- |e VerfasserIn |0 (DE-588)1076301991 |0 (DE-627)834660377 |0 (DE-576)445184582 |4 aut | |
| 245 | 1 | 0 | |a Investigating the additive interaction of QT-prolonging drugs in older people using claims data |c Andreas D. Meid, Anna von Medem, Dirk Heider, Jürgen-Bernhard Adler, Christian Günster, Hanna M. Seidling, Renate Quinzler, Hans-Helmut König, Walter E. Haefeli |
| 264 | 1 | |c 2017 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First online: 29 November 2016 | ||
| 500 | |a Gesehen am 24.09.2018 | ||
| 520 | |a IntroductionDrugs that potentially prolong the QT interval carry the risk of life-threatening Torsades de pointes (TdP) ventricular arrhythmia.ObjectiveThe objective of this study was to investigate the potential additive risk for ventricular arrhythmia with concomitant prescriptions of QT-prolonging drugs.MethodsClaims data for persons aged ≥65 years between 2010 and 2012 in Germany were analyzed and all cases hospitalized for ventricular arrhythmia were selected. In a case-crossover analysis, exposure with QT-prolonging drugs according to the Arizona Center for Education and Research on Therapeutics (AZCERT) classification of ‘known,’ ‘conditional,’ and ‘possible’ TdP risk was determined in respective event and control windows preceding hospitalization. Conditional logistic regression was applied to derive odds ratios (ORs).ResultsAmong 6,849,622 health-insured persons, we identified 2572 patients newly hospitalized for ventricular arrhythmia. Drugs with ‘known’ risk were more frequently prescribed in the event window than in the control window (309 vs. 239; P < 0.001). The number of drugs with an attributed ‘known’ risk of TdP was significantly associated with hospitalization for ventricular arrhythmia (OR: 2.22; 95% confidence interval [1.51-3.25]; P < 0.001), while increased risk estimates were also obtained upon categorization into one and two or more drugs compared with no drugs for the combined group of drug with ‘known’ (1.52 [1.16-2.00]) and ‘conditional’ risk (2.20 [1.42-3.41]). Pairwise comparisons and trend tests based on these classification categories could not demonstrate a significantly increased risk of two or more drugs compared with one drug.ConclusionBeyond suitable single-drug classifications for QT-associated risk estimation, the situation when there is co-prescription of several drugs appears to be complex and may not be extrapolated to all possible multi-drug combinations. | ||
| 650 | 4 | |a Cardiac Repolarization | |
| 650 | 4 | |a Claim Data | |
| 650 | 4 | |a Event Window | |
| 650 | 4 | |a Terfenadine | |
| 650 | 4 | |a Ventricular Arrhythmia | |
| 700 | 1 | |a Medem, Anna von |d 1985- |e VerfasserIn |0 (DE-588)1167717384 |0 (DE-627)1031235787 |0 (DE-576)511229925 |4 aut | |
| 700 | 1 | |a Seidling, Hanna |d 1982- |e VerfasserIn |0 (DE-588)140696512 |0 (DE-627)703758861 |0 (DE-576)319591433 |4 aut | |
| 700 | 1 | |a Quinzler, Renate |d 1976- |e VerfasserIn |0 (DE-588)133903907 |0 (DE-627)557959039 |0 (DE-576)277558190 |4 aut | |
| 700 | 1 | |a Haefeli, Walter E. |d 1958- |e VerfasserIn |0 (DE-588)124572359 |0 (DE-627)656806141 |0 (DE-576)340514221 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drug safety |d Berlin [u.a.] : Springer, 1990 |g 40(2017), 2, Seite 133-144 |h Online-Ressource |w (DE-627)320630714 |w (DE-600)2023894-0 |w (DE-576)273879081 |x 1179-1942 |7 nnas |a Investigating the additive interaction of QT-prolonging drugs in older people using claims data |
| 773 | 1 | 8 | |g volume:40 |g year:2017 |g number:2 |g pages:133-144 |g extent:12 |a Investigating the additive interaction of QT-prolonging drugs in older people using claims data |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40264-016-0477-y |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/content/pdf/10.1007%2Fs40264-016-0477-y.pdf |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180924 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 124572359 |a Haefeli, Walter E. |m 124572359:Haefeli, Walter E. |d 910000 |d 910100 |e 910000PH124572359 |e 910100PH124572359 |k 0/910000/ |k 1/910000/910100/ |p 9 |y j | ||
| 998 | |g 133903907 |a Quinzler, Renate |m 133903907:Quinzler, Renate |d 910000 |d 910100 |e 910000PQ133903907 |e 910100PQ133903907 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 140696512 |a Seidling, Hanna |m 140696512:Seidling, Hanna |d 910000 |d 910100 |e 910000PS140696512 |e 910100PS140696512 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1167717384 |a Medem, Anna von |m 1167717384:Medem, Anna von |d 910000 |d 910100 |e 910000PM1167717384 |e 910100PM1167717384 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1076301991 |a Meid, Andreas |m 1076301991:Meid, Andreas |d 910000 |d 910100 |e 910000PM1076301991 |e 910100PM1076301991 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1581230028 |e 3026409014 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Andreas D. Meid, Anna von Medem, Dirk Heider, Jürgen-Bernhard Adler, Christian Günster, Hanna M. Seidling, Renate Quinzler, Hans-Helmut König, Walter E. Haefeli"]},"person":[{"display":"Meid, Andreas","family":"Meid","role":"aut","roleDisplay":"VerfasserIn","given":"Andreas"},{"display":"Medem, Anna von","given":"Anna von","role":"aut","roleDisplay":"VerfasserIn","family":"Medem"},{"display":"Seidling, Hanna","family":"Seidling","given":"Hanna","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Quinzler","roleDisplay":"VerfasserIn","role":"aut","given":"Renate","display":"Quinzler, Renate"},{"given":"Walter E.","roleDisplay":"VerfasserIn","role":"aut","family":"Haefeli","display":"Haefeli, Walter E."}],"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"id":{"doi":["10.1007/s40264-016-0477-y"],"eki":["1581230028"]},"title":[{"title":"Investigating the additive interaction of QT-prolonging drugs in older people using claims data","title_sort":"Investigating the additive interaction of QT-prolonging drugs in older people using claims data"}],"note":["First online: 29 November 2016","Gesehen am 24.09.2018"],"relHost":[{"origin":[{"publisher":"Springer ; Adis Internat. Ltd.","dateIssuedDisp":"1990-","publisherPlace":"Berlin [u.a.] ; Mairangi Bay, New Zealand","dateIssuedKey":"1990"}],"title":[{"title":"Drug safety","subtitle":"reviews of adverse drug experience and risk benefit ; evaluations in disease management","title_sort":"Drug safety"}],"pubHistory":["5.1990 -"],"id":{"issn":["1179-1942"],"eki":["320630714"],"zdb":["2023894-0"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"text":"40(2017), 2, Seite 133-144","issue":"2","extent":"12","volume":"40","year":"2017","pages":"133-144"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"320630714","note":["Gesehen am 17.04.14"],"disp":"Investigating the additive interaction of QT-prolonging drugs in older people using claims dataDrug safety"}],"recId":"1581230028","type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"12 S."}],"language":["eng"]} | ||
| SRT | |a MEIDANDREAINVESTIGAT2017 | ||